βιοδεικτες

Bibliographic Records

Biomarkers in Parkinson’s disease – the PPMI study (Parkinson’s Progression Markers Initiative)

Given recent advances in the understanding of the pathogenesis of Parkinson’s disease and the prospects of neuroprotective therapies, it is imperative to develop novel biomarkers which could facilitate the diagnosis and follow up of afflicted patients. Such biomarkers could involve

Five-year biomarker progression variability for Alzheimer’s disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?

INTRODUCTION: Biomarker developments explain higher variability in cognitive decline than baseline values alone. This study examines the development of established biomarkers along with a novel marker in longitudinal cognitive decline.METHODS:A total of 215 subjects were selected with a diagnosis of

Dietary-depression and cognitive impairment among eldery: a population based approach in a closed geographical area of Magnesia

There is accumulating evidence on the association between vitamin complex B levels in blood and the risk of depression and/or cognitive impairment among elderly people. In the context of the “VELESTINO” study, data were collected through interviewer-administered questionnaires and blood